Advertisement
Canada markets open in 1 hour 15 minutes

  • S&P/TSX

    21,740.20
    -159.79 (-0.73%)
     

  • S&P 500

    5,061.82
    -61.59 (-1.20%)
     

  • DOW

    37,735.11
    -248.13 (-0.65%)
     

  • CAD/USD

    0.7255
    +0.0002 (+0.02%)
     

  • CRUDE OIL

    84.81
    -0.60 (-0.70%)
     

  • Bitcoin CAD

    86,911.20
    -4,192.71 (-4.60%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,388.20
    +5.20 (+0.22%)
     

  • RUSSELL 2000

    1,975.71
    -27.47 (-1.37%)
     

  • 10-Yr Bond

    4.6280
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,896.00
    +19.75 (+0.11%)
     

  • VOLATILITY

    18.57
    -0.66 (-3.43%)
     

  • FTSE

    7,871.24
    -94.29 (-1.18%)
     

  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     

  • CAD/EUR

    0.6816
    -0.0008 (-0.12%)
     
MARKETS LIVE BLOG:

DOW FUTURES UP MORE THAN 200 POINTS AS EARNINGS ROLL IN

Bond yields continue to rise after 10-year Treasury yield touched 2024 highs on Monday

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Kadmon Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 2, 2021 - KDMN

Newsfile Corp.
·2 min read

New York, New York--(Newsfile Corp. - April 12, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Kadmon Holdings, Inc. ("Kadmon Holdings") (NASDAQ: KDMN) between October 1, 2020 and March 10, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Eastern District of New York. To get more information go to:

https://www.zlk.com/pslra-1/kadmon-holdings-inc-loss-submission-form?prid=14614&wire=5

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) the Belumosudil NDA was incomplete and/or deficient; (ii) the additional new data that the Company submitted in support of the Belumosudil NDA in response to an information request from the FDA materially altered the NDA submission; (iii) accordingly, the initial Belumosudil NDA submission lacked the degree of support that the Company had led investors to believe; (iv) accordingly, the FDA was likely to extend the PDUFA target action date to review the Belumosudil NDA; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

ADVERTISEMENT

If you suffered a loss in Kadmon Holdings you have until June 2, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/80238